We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Study - ILM Peeling

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01083056
First Posted: March 9, 2010
Last Update Posted: July 31, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
M. Dominik Fischer, University Hospital Tuebingen
  Purpose
This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.

Condition
Epimacular Gliosis Macular Hole

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling

Further study details as provided by M. Dominik Fischer, University Hospital Tuebingen:

Primary Outcome Measures:
  • BCVA [ Time Frame: 6 months after ILM peeling ]

Enrollment: 10
Study Start Date: March 2010
Study Completion Date: July 2014
Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Epimacular Gliosis Without Macular Hole
Epimacular Gliosis With Macular Hole

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Inpatients at the University Eye Hospital Tuebingen
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Epimacular Gliosis
  • Must be scheduled for ILM-peeling independently of study
  • Must be older then 18 years of age

Exclusion Criteria:

  • Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
  • Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01083056


Locations
Germany
Centre for Ophthalmology, University Hospital Tuebingen
Tuebingen, BW, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
Principal Investigator: Florian Gekeler, MD Centre for Ophthalmology, University Hospital Tuebingen
  More Information

Responsible Party: M. Dominik Fischer, PD Dr. med. M. Dominik Fischer, University Hospital Tuebingen
ClinicalTrials.gov Identifier: NCT01083056     History of Changes
Other Study ID Numbers: ILM Peeling
First Submitted: March 8, 2010
First Posted: March 9, 2010
Last Update Posted: July 31, 2014
Last Verified: July 2014

Keywords provided by M. Dominik Fischer, University Hospital Tuebingen:
retina
gliosis
macula
membrane
ILM

Additional relevant MeSH terms:
Retinal Perforations
Gliosis
Retinal Diseases
Eye Diseases
Pathologic Processes